Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia

Some patients with acute myeloid leukemia (AML) who are in complete remission after induction chemotherapy harbor persisting pre-leukemic clones, carrying a subset of leukemia-associated somatic mutations. There is conflicting evidence on the prognostic relevance of these clones for AML relapse. Her...

Descripción completa

Detalles Bibliográficos
Autores principales: Rothenberg-Thurley, Maja, Amler, Susanne, Goerlich, Dennis, Köhnke, Thomas, Konstandin, Nikola P., Schneider, Stephanie, Sauerland, Maria C., Herold, Tobias, Hubmann, Max, Ksienzyk, Bianka, Zellmeier, Evelyn, Bohlander, Stefan K., Subklewe, Marion, Faldum, Andreas, Hiddemann, Wolfgang, Braess, Jan, Spiekermann, Karsten, Metzeler, Klaus H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035153/
https://www.ncbi.nlm.nih.gov/pubmed/29472724
http://dx.doi.org/10.1038/s41375-018-0034-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035153/
https://www.ncbi.nlm.nih.gov/pubmed/29472724
http://dx.doi.org/10.1038/s41375-018-0034-z

Ejemplares similares